Бенарин Drug photo

The description is actual on 11.06.2016

  • Latin name: Benarin
  • ATH code: R01AD05
  • Active ingredient: Budesonid
  • Producer: CJSC Pulmomed (Russia)


Drops nasal contain 0,5 mg on ml of active agent budesonid.

Act as additional components: thiourea, propylene glycol, nipazol, poly(ethylene oxide), Trilonum of B, acid the benzoic and amber, clear water.

Release form

Benarin is issued in the form of nasal drops, spray.

Pharmacological action


Pharmacodynamics and pharmacokinetics

Active ingredient – budesonid. Makes antiallergenic and antiinflammatory impact.

The principle of action is based on strengthening of development of a lipokortin — A2 phospholipase inhibitor that leads to decrease in production of arachidonic acid, oppression of process of synthesizing of prostaglandins and endoperoxides which are products of a metabolism of arachidonic acid.

Benarin reduces the speed of processes of granulation and an infiltration, slows down migration of macrophages, inhibits chemotaxis substance forming, reduces products of cytokines, reduces inflammatory exudation, prevents forming of regional accumulation of neutrophils.

Under the influence of a budesonid release of mediators of an inflammation from mast cells decreases that slows down development of chronic rhinitis and a chain of allergic reactions.

At prolonged use Benarin is well had, does not possess resorptive action.

The significant therapeutic effect forms in 1-3 weeks.

Indications to use

Benarin is shown at allergic rhinitis (year-round and seasonal options of a current).

Spray Benarin is applied at inflammatory processes in a nasal cavity of noninfectious genesis, to prevention of growth of polyps in a nasal cavity, is effective at vasculomotor rhinitis.


Benarin do not appoint at a pulmonary tuberculosis, viral, fungal and bacterial damages of respiratory system.

Budesonid is not applied at fresh injuries of a nose, in the acute period after surgical interventions on a nasal cavity, at pregnancy, at chest feeding, in pediatric practice before achievement of age of majority.

Side effects

Drug use Benarin can be followed by irritation of a mucous membrane in a nasal cavity, a burning sensation, an itch.

Development of bleeding, allergic reactions, a headache, irritation in a throat, sneezing, dizzinesses is possible.

Seldom the ulceration, a mucosal atrophy, increase of intraocular pressure, a conjunctiva hyperemia, perforation of a nasal partition, dispepsichesky frustration, cough, the increased drowsiness, a mialgiya, vomiting, growth delay, throat candidiasis, candidiasis of a nasal cavity, a nose congestion, a cardiopalmus, a gastralgia is registered.

Benarin, application instruction (Way and dosage)

Spray Benarin: on 2 injections (totally 100 mkg) in each nasal course, twice a day. A maintenance therapy – on 1 dose twice a day, or a double dose in the morning.

Drops Benarin: on 2-3 drops (50-150 mkg) to dig in in each nasal course. A day no more than 400 mkg. A therapy course till 3 months. At the admission of a dose drug is used in the shortest possible time, the planned dose has to come to an organism not earlier, than in an hour.


At overdose the syndrome of Kushinga, acne rash, a dysmenorrhea forms.

Gradual decrease in drug doses Benarin is recommended.


Ketokonazol, estrogen and methandrostenolone increase Benarin's efficiency.

Rifampicin, phenobarbital and Phenytoinum – reduce efficiency of drug.

Terms of sale

The recipe is required.

Storage conditions

In the dark place, unavailable to children, at a temperature no more than 25 degrees Celsius.

Period of validity

No more than two years.

Special instructions

At hit of medicine in eyes the keratohelcosis forms.

Transition from a system glucocorticosteroid to a glucocorticosteroid of local action can provoke development of a syndrome of adrenal insufficiency.

Achievement of therapeutic effect at treatment of allergic rhinitis is carried out at regular use of medicine.

Benarin's analogs

Analogs are: Benakort, Budenit, Budenofalk, Budesonid, Pulmikort, Tafen.

Section: Hormonal From an allergy
in more detail

Education: Graduated from the Bashkir state medical university majoring in "Medical business". In 2011 gained the diploma and the certificate in Therapy. In 2012 received 2 certificate and the diploma in "Functional diagnosis" and "Cardiology". In 2013 completed courses on "Topical issues of otorhinolaryngology in therapy". In 2014 completed advanced training courses in "A clinical echocardiography" and courses in "Medical rehabilitation".

Experience: From 2011 to 2014 the Policlinic No. 33 Ufa worked as the therapist and the cardiologist in MBUZ. Since 2014 the Policlinic No. 33 Ufa works as the cardiologist and the doctor of functional diagnosis in MBUZ.

PAY ATTENTION! Information on drugs on the website is help generalizing, collected from public sources and can form the basis for making decision on use of medicines it is not aware of treatment. Before medicine use Benarin surely consult with the attending physician.